Strategies for monitoring subvisible particles in biopharmaceutical formulations are central to developing and manufacturing safe, effective drug products. Our recently presented webinar introduces flow imaging microscopy (FIM), an analytical technique commonly used to characterize subvisible particle content in biotherapeutic samples. This webinar is now available for viewing on demand.
In the webinar, we describe how flow imaging microscopy works and relates to other particle characterization methods, and how FlowCam, a flow imaging microscope, can support the development of safe, high-quality biotherapeutics. We review examples for protein and cell & gene therapy applications, followed by an engaging Q&A session.
By watching this webinar, you'll enhance your understanding of:
- The importance of monitoring subvisible particles in biotherapeutic drug products to improve product quality
- How FlowCam works and can be used to characterize protein stability in formulations
- Advantages of flow imaging microscopy over other particle analysis techniques
Learn more about FlowCam
FlowCam offers a full portfolio of particle imaging instruments to count, size, and determine the morphology of particles from 300 nm to more than 100 µm in size in biopharmaceutical formulations, including protein, cell, and gene therapies.
